Optimising infliximab induction dosing to achieve clinical remission in Chinese patients with Crohn's disease

• Main Authors: Kouzhu Zhu (Author), Xiaoliang Ding (Author), Ling Xue (Author), Linsheng Liu (Author), Yan Wang (Author), Yun Li (Author), Qinhua Xi (Author), Xueqin Pang (Author), Weichang Chen (Author), Liyan Miao (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

AimsA strategy based on therapeutic drug monitoring and population pharmacokinetic (popPK) models would likely increase the rate of clinical remission (CR) after infliximab (IFX) induction in patients with Crohn's disease (CD). This study aimed to evaluate the relationship between early IFX lev...